-
Investigating the effect of conventional chemotherapies, Cisplatin and Doxorubicin, in combination with a nuclear transport inhibitor, INI-43, on cerfical cancer cells
-
Investigating a novel small molecule inhibitor of nuclear import as an anti-cancer approach
-
Small molecule inhibitors of parasitic enzymes
-
Characterising the anticancer effects of a small molecule with potential to inhibit nuclear import via karyopherin beta1
-
Synthesis of polymer-bound small-molecule kinase inhibitors as anti-tumour agents
-
Clinical candidates of small molecule p38 MAPK inhibitors for inflammatory diseases
-
Investigating Karyopherin B1: small molecule interactions for cancer therapy
-
Identification of Novel Small‐Molecule Inhibitors Targeting KDM5B and Evaluation of Their Antitumour Effects
-
Investigating the nuclear import protein KPn߀1 as a cancer therapeutic target
-
Synthesis of small molecule bioactive compounds with potential anti–cancer activity
-
Contents 43(2)
-
Contents 43(1)
-
Evaluation of small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 for their radiomodulatory effects in human breast cancer cell lines
-
A small molecule inhibitor of RNA-binding protein IGF2BP3 shows anti-leukemic activity
-
Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
-
Modulating the expression and activity of the nuclear import protein, Karyopherin β1, in cancer cells
-
Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens
-
43 | Synergistic negative effects of advanced glycation end products and tumor-conditioned medium on C2C12 myotubes and the protective activity of Vaccinium macrocarpon
-
Eienskappe van energietoestande in 43K
-
Molecular interactions of the T cell regulatory molecule CD5
-
Guía Europea de Medicina Nuclear
-
Investigation of the efficacy of identified acetolactate synthase inhibitors, peptidyl cysteine protease inhibitors, thiolactomycins, and thiosemicarbazone compounds against Mycobacterium tuberculosis
-
Full Issue - Volume 43, Issue 2
-
Analysis of the Recovery of Immune Status in the Patients With Paroxysmal Nocturnal Hemoglobinuria After Treatment With C5 Complement Inhibitor
